ArticleOncotarget2016

MK-8776, a novel chk1 kinase inhibitor, radiosensitizes p53-defective human tumor cells.

Kathleen A Bridges et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.